Holding(s) in Company

RNS Number : 8935N
Tissue Regenix Group PLC
21 May 2015
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Tissue Regenix Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
iii

IP Group plc

4. Full name of shareholder(s)
 (if different from 3.):iv

See section 9

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

19 May 2015

6. Date on which issuer notified:

20 May 2015

7. Threshold(s) that is/are crossed or
reached:
vi, vii

 

Direct interests: unchanged

Indirect interests: Below 3%

Combined direct and indirect interests: 14% reached

 



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct xi

Indirect xii

Direct

Indirect

Ordinary 0.5p Shares

 

127,837,566

 

127,837,566

 

 

110,837,566

 

 

103,042,836

 

7,794,730

 

13.56%

 

1.03%

GB00B5SGVL29


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

110,837,566

 

14.59%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

Direct interests:

 

Techtran Group Limited - 103,042,836

 

Techtran Group Limited is a 100% owned subsidiary of IP Group plc.

 

Indirect interests:

 

IP Venture Fund - 7,794,730

 

IP Venture Fund is a limited partnership fund that is managed by Top Technology Ventures Limited, a 100% subsidiary of IP Group plc.

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:



13. Additional information:

This notification relates to reductions in the holdings in the issuer by IP Venture Fund. IP Group's direct holdings are unchanged.

 

Based on 759,653,093 Ordinary Shares in issue

14. Contact name:

Greg Smith

15. Contact telephone number:

020 7444 0050

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUASWRVNAVURR
UK 100

Latest directors dealings